Genomic Expression

Commercial Stage RNA Platform For Next Generation Cures. By analyzing RNA we can detect disease, monitor health and design next generation cures. Focus on women cancer and infectious disease. Regulatory approvals obtained. Recurring customers, partnered with handful of clinical sites including Rutgers cancer center and US National Cancer Institute. Top 10 of the XTC, presented for Richard Branson at Necker island, won the Lyfebulb and the EUTop50 award, and presented at the UN and the European Parliament, semi-finals of XPRIZE. | TRL: 9 |  TAM: $20B, Women $3B | Series A  | Next step : commercial acceleration | EUR 20M, Bridge of $1M sought – Denmark/USA